Cracking the code of therapeutic failure in inflammatory rheumatic diseases: collaborative pathways bridging academia, industry, and patient-centric innovation
Annals of the Rheumatic Diseases · 2026-06 · 85 (6) · 984-990
DOI: 10.1016/j.ard.2025.12.007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Annals of the Rheumatic Diseases, 2026-06. Verfasst von Kenneth F Baker und 10 weiteren Autor:innen. Beteiligte Einrichtung: Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK; NIHR Newcastle Biomedical Research Centre (BRC), Newcas…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research, NIHR Newcastle Biomedical Research Centre, Foundation for Research in Rheumatology.
Abstract (Originalsprache)
Close collaboration between academia and industry has formed the cornerstone of a therapeutic revolution in the management and clinical outcomes of patients living with inflammatory rheumatic musculoskeletal diseases (RMDs), driven by early diagnosis, treat-to-target strategies, and novel targeted therapies [1]. However, despite these remarkable advances, disease control can often be suboptimal for many patients, including partial or complete failure of clinical response, or secondary loss of efficacy even after extended periods of drug-induced remission.
Autor:innen und Institutionen
- Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK; NIHR Newcastle Biomedical Research Centre (BRC), Newcastle upon Tyne, UK. Electronic address: kenneth.baker@ncl.ac.uk.
- Centre for Rheumatic Diseases, Faculty of Life Sciences and Medicine, King's College London, London, UK.
- Translational Medicine, Immunology; Novartis Pharma, Basel, Switzerland.
- European Medical Affairs, UCB, Luzern, Switzerland.
- Inflammation and Immunology Research Unit, Pfizer Inc., Cambridge, MA, USA.
- AbbVie Inc., North Chicago, IL, USA.
Förderung
- National Institute for Health and Care Research
- NIHR Newcastle Biomedical Research Centre
- Foundation for Research in Rheumatology
Zitieren
APA
Baker, K. F., Nikiphorou, E., Cavalli, G., Ganz, F., Hegen, M., Reinke-Breen, L., Sharaf, M., Helm-van Mil, A. H. M. V., Bijlsma, J. W. J., McInnes, I., & FOREUM Boot Camp Working Group (2026). Cracking the code of therapeutic failure in inflammatory rheumatic diseases: collaborative pathways bridging academia, industry, and patient-centric innovation. Annals of the Rheumatic Diseases, 85(6), 984-990. https://doi.org/10.1016/j.ard.2025.12.007
Vancouver
Baker KF, Nikiphorou E, Cavalli G, Ganz F, Hegen M, Reinke-Breen L, et al. Cracking the code of therapeutic failure in inflammatory rheumatic diseases: collaborative pathways bridging academia, industry, and patient-centric innovation. Annals of the Rheumatic Diseases. 2026;85(6):984-990. doi:10.1016/j.ard.2025.12.007
BibTeX
@article{Baker2026,
author = {Baker, Kenneth F and Nikiphorou, Elena and Cavalli, Giulio and Ganz, Fabiana and Hegen, Martin and Reinke-Breen, Lauren and Sharaf, Mohamed and Helm-van Mil, Annette H M van der and Bijlsma, Johannes W J and McInnes, Iain and FOREUM Boot Camp Working Group, FOREUM Boot Camp Working Group},
title = {Cracking the code of therapeutic failure in inflammatory rheumatic diseases: collaborative pathways bridging academia, industry, and patient-centric innovation},
journal = {Annals of the Rheumatic Diseases},
year = {2026},
volume = {85},
number = {6},
pages = {984--990},
doi = {10.1016/j.ard.2025.12.007}
}
EUVIMED